Hamostaseologie 2021; 41(04): 257-266
DOI: 10.1055/a-1306-4327
Review Article

Ovarian Vein Thrombosis: A Narrative Review

Nicoletta Riva
1   Department of Anatomy, Faculty of Medicine and Surgery, University of Malta, Msida, Malta
2   Department of Pathology, Faculty of Medicine and Surgery, University of Malta, Msida, Malta
,
Jean Calleja-Agius
1   Department of Anatomy, Faculty of Medicine and Surgery, University of Malta, Msida, Malta
› Author Affiliations

Abstract

Ovarian vein thrombosis (OVT) is a rare type of venous thromboembolism. The most common risk factors for OVT include pregnancy, oral contraceptives, malignancies, recent surgery, and pelvic infections; however, in 4 to 16% of cases, it can be classified as idiopathic. Most of the available information regards pregnancy-related OVT, which has been reported to complicate 0.01 to 0.18% of pregnancies and to peak around 2 to 6 days after delivery or miscarriage/abortion. The right ovarian vein is more frequently involved (70–80% of cases). Clinical features of OVT include abdominal pain and tenderness, fever, and gastrointestinal symptoms. The most typical finding is the presence of a palpable abdominal mass, although reported in only 46% of cases. OVT can be the cause of puerperal fever in approximately a third of women. Ultrasound Doppler is the first-line imaging, because of its safety, low cost, and wide availability. However, the ovarian veins are difficult to visualize in the presence of bowel meteorism or obesity. Thus, computed tomography or magnetic resonance imaging is often required to confirm the presence and extension of the thrombosis. In oncological patients, OVT is often an incidental finding at abdominal imaging. Mortality related to OVT is nowadays low due to the combination treatment of parenteral broad-spectrum antibiotics (until at least 48 hours after fever resolution) and anticoagulation (low-molecular-weight heparin, vitamin K antagonists, or direct oral anticoagulants). Anticoagulant treatment duration of 3 to 6 months has been recommended for postpartum OVT, while no anticoagulation has been suggested for incidentally detected cancer-associated OVT.



Publication History

Received: 06 June 2020

Accepted: 06 November 2020

Article published online:
21 December 2020

© 2020. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References

  • 1 Drake RL, Vogl AW, MItchell AWM. Gray's Anatomy for Students, 4th ed. Canada: Elsevier; 2020
  • 2 Karaosmanoglu D, Karcaaltincaba M, Karcaaltincaba D, Akata D, Ozmen M. MDCT of the ovarian vein: normal anatomy and pathology. AJR Am J Roentgenol 2009; 192 (01) 295-299
  • 3 Bhutta HY, Walsh SR, Tang TY, Walsh CA, Clarke JM. Ovarian vein syndrome: a review. Int J Surg 2009; 7 (06) 516-520
  • 4 Gupta R, Gupta A, Aggarwal N. Variations of gonadal veins: embryological prospective and clinical significance. J Clin Diagn Res 2015; 9 (02) AC08-AC10
  • 5 Lenz CJ, Wysokinski WE, Henkin S. et al. Ovarian vein thrombosis: incidence of recurrent venous thromboembolism and survival. Obstet Gynecol 2017; 130 (05) 1127-1135
  • 6 Brown TK, Munsick RA. Puerperal ovarian vein thrombophlebitis: a syndrome. Am J Obstet Gynecol 1971; 109 (02) 263-273
  • 7 Dunnihoo DR, Gallaspy JW, Wise RB, Otterson WN. Postpartum ovarian vein thrombophlebitis: a review. Obstet Gynecol Surv 1991; 46 (07) 415-427
  • 8 Rottenstreich A, Da'as N, Kleinstern G, Spectre G, Amsalem H, Kalish Y. Pregnancy and non-pregnancy related ovarian vein thrombosis: clinical course and outcome. Thromb Res 2016; 146: 84-88
  • 9 Brown CE, Stettler RW, Twickler D, Cunningham FG. Puerperal septic pelvic thrombophlebitis: incidence and response to heparin therapy. Am J Obstet Gynecol 1999; 181 (01) 143-148
  • 10 Salomon O, Dulitzky M, Apter S. New observations in postpartum ovarian vein thrombosis: experience of single center. Blood Coagul Fibrinolysis 2010; 21 (01) 16-19
  • 11 Klima DA, Snyder TE. Postpartum ovarian vein thrombosis. Obstet Gynecol 2008; 111 (2, Pt 1): 431-435
  • 12 Aguilar S, Cunha V, Martins L, Colaço J, Nunes F, Kayryakova M. Ovarian vein thrombosis: a case report. Int J Med Rev Case Rep 2019; 3 (08) 494-498
  • 13 Assal A, Kaner JD, Danda N, Cohen HW, Billett HH. Risk factors and prognosis of ovarian vein thrombosis. Blood Coagul Fibrinolysis 2017; 28 (06) 468-474
  • 14 Mantha S, Sarasohn D, Ma W. et al. Ovarian vein thrombosis after debulking surgery for ovarian cancer: epidemiology and clinical significance. Am J Obstet Gynecol 2015; 213 (02) 208.e1-208.e4
  • 15 Virchow R. Thrombose und embolie. Gefässentzündung und septische infektion. Gesammelte Abhandlungen zur wissenschaftlichen Medicin. Frankfurt am Main: Von Meidinger & Sohn; 1856: 219-732
  • 16 Villani M, Ageno W, Grandone E, Dentali F. The prevention and treatment of venous thromboembolism in pregnancy. Expert Rev Cardiovasc Ther 2017; 15 (05) 397-402
  • 17 Brenner B. Haemostatic changes in pregnancy. Thromb Res 2004; 114 (5-6): 409-414
  • 18 Osman MW, Nikolopoulos I, Jayaprakasan K, Raine-Fenning N. Pelvic congestion syndrome. Obstet Gynaecol 2013; 15: 151-157
  • 19 Rooholamini SA, Au AH, Hansen GC. et al. Imaging of pregnancy-related complications. Radiographics 1993; 13 (04) 753-770
  • 20 Virmani V, Kaza R, Sadaf A, Fasih N, Fraser-Hill M. Ultrasound, computed tomography, and magnetic resonance imaging of ovarian vein thrombosis in obstetrical and nonobstetrical patients. Can Assoc Radiol J 2012; 63 (02) 109-118
  • 21 Gakhal MS, Levy HM, Spina M, Wrigley C. Ovarian vein thrombosis: analysis of patient age, etiology, and side of involvement. Del Med J 2013; 85 (02) 45-50 , quiz 59
  • 22 Kominiarek MA, Hibbard JU. Postpartum ovarian vein thrombosis: an update. Obstet Gynecol Surv 2006; 61 (05) 337-342
  • 23 Durham JD, Machan L. Pelvic congestion syndrome. Semin Intervent Radiol 2013; 30 (04) 372-380
  • 24 Dougan C, Phillips R, Harley I, Benson G, Anbazhagan A. Postpartum ovarian vein thrombosis. Obstet Gynaecol 2016; 18: 291-299
  • 25 Wysokinska EM, Hodge D, McBane II RD. Ovarian vein thrombosis: incidence of recurrent venous thromboembolism and survival. Thromb Haemost 2006; 96 (02) 126-131
  • 26 Rickles FR, Falanga A. Activation of clotting factors in cancer. Cancer Treat Res 2009; 148: 31-41
  • 27 Falanga A, Marchetti M, Vignoli A. Coagulation and cancer: biological and clinical aspects. J Thromb Haemost 2013; 11 (02) 223-233
  • 28 Yassa NA, Ryst E. Ovarian vein thrombosis: a common incidental finding in patients who have undergone total abdominal hysterectomy and bilateral salpingo-oophorectomy with retroperitoneal lymph node dissection. AJR Am J Roentgenol 1999; 172 (01) 45-47
  • 29 Gupta A, Gupta N, Blankstein J, Trester R. Ovarian vein thrombosis as a complication of laparoscopic surgery. Case Rep Obstet Gynecol 2015; 2015: 682941
  • 30 Tanaka Y, Kato H, Hosoi A, Isobe M, Koyama S, Shiki Y. Ovarian vein thrombosis following total laparoscopic hysterectomy. Asian J Endosc Surg 2012; 5 (04) 179-182
  • 31 Al-Achmar SN, Stavrou S, Protopapas A, Drakakis P, Siemou P, Chatzipapas I. Ovarian vein thrombosis after total laparoscopic hysterectomy with unilateral adnexectomy: a case report. Int J Surg Case Rep 2017; 41: 1-4
  • 32 Drozdinsky G, Hadar E, Shmueli A, Gabbay-Benziv R, Shiber S. Obstetric antiphospholipid syndrome and long term arterial thrombosis risk. J Thromb Thrombolysis 2017; 44 (03) 371-375
  • 33 André M, Delèvaux I, Amoura Z. et al. Ovarian vein thrombosis in the antiphospholipid syndrome. Arthritis Rheum 2004; 50 (01) 183-186
  • 34 Salomon O, Apter S, Shaham D. et al. Risk factors associated with postpartum ovarian vein thrombosis. Thromb Haemost 1999; 82 (03) 1015-1019
  • 35 Valerio L, Riva N. Head, neck and abdominopelvic septic thrombophlebitis: current evidence and challenges in diagnosis and treatment. Hamostaseologie 2020; 40 (03) 301-310
  • 36 Dotters-Katz SK, Smid MC, Grace MR, Thompson JL, Heine RP, Manuck T. Risk factors for postpartum septic pelvic thrombophlebitis: a multicenter cohort. Am J Perinatol 2017; 34 (11) 1148-1151
  • 37 Garcia J, Aboujaoude R, Apuzzio J, Alvarez JR. Septic pelvic thrombophlebitis: diagnosis and management. Infect Dis Obstet Gynecol 2006; 2006: 15614
  • 38 Labropoulos N, Malgor RD, Comito M, Gasparis AP, Pappas PJ, Tassiopoulos AK. The natural history and treatment outcomes of symptomatic ovarian vein thrombosis. J Vasc Surg Venous Lymphat Disord 2015; 3 (01) 42-47
  • 39 Sinha D, Yasmin H, Samra JS. Postpartum inferior vena cava and ovarian vein thrombosis---a case report and literature review. J Obstet Gynaecol 2005; 25 (03) 312-313
  • 40 Akinbiyi AA, Nguyen R, Katz M. Postpartum ovarian vein thrombosis: two cases and review of literature. Case Rep Med 2009; 2009: 101367
  • 41 Brown CE, Lowe TW, Cunningham FG, Weinreb JC. Puerperal pelvic thrombophlebitis: impact on diagnosis and treatment using x-ray computed tomography and magnetic resonance imaging. Obstet Gynecol 1986; 68 (06) 789-794
  • 42 Kubik-Huch RA, Hebisch G, Huch R, Hilfiker P, Debatin JF, Krestin GP. Role of duplex color Doppler ultrasound, computed tomography, and MR angiography in the diagnosis of septic puerperal ovarian vein thrombosis. Abdom Imaging 1999; 24 (01) 85-91
  • 43 Jacoby WT, Cohan RH, Baker ME, Leder RA, Nadel SN, Dunnick NR. Ovarian vein thrombosis in oncology patients: CT detection and clinical significance. AJR Am J Roentgenol 1990; 155 (02) 291-294
  • 44 Khalil H, Avruch L, Olivier A, Walker M, Rodger M. The natural history of pelvic vein thrombosis on magnetic resonance venography after vaginal delivery. Am J Obstet Gynecol 2012; 206 (04) 356.e1-356.e4
  • 45 Rodger MA, Avruch LI, Howley HE, Olivier A, Walker MC. Pelvic magnetic resonance venography reveals high rate of pelvic vein thrombosis after cesarean section. Am J Obstet Gynecol 2006; 194 (02) 436-437
  • 46 Giraud JR, Poulain P, Renaud-Giono A. et al. Diagnosis of post-partum ovarian vein thrombophlebitis by color Doppler ultrasonography: about 10 cases. Acta Obstet Gynecol Scand 1997; 76 (08) 773-778
  • 47 Hadas-Halpern I, Patlas M, Fisher D. Postpartum ovarian vein thrombophlebitis: sonographic diagnosis. Abdom Imaging 2002; 27 (01) 93-95
  • 48 Twickler DM, Setiawan AT, Evans RS. et al. Imaging of puerperal septic thrombophlebitis: prospective comparison of MR imaging, CT, and sonography. AJR Am J Roentgenol 1997; 169 (04) 1039-1043
  • 49 Sharma P, Abdi S. Ovarian vein thrombosis. Clin Radiol 2012; 67 (09) 893-898
  • 50 Smith MD, Felker RE, Emerson DS, Livingston JC, Egerman RS. Sonographic visualization of ovarian veins during the puerperium: an assessment of efficacy. Am J Obstet Gynecol 2002; 186 (05) 893-895
  • 51 Lee EH, Im CY, Kim JW. Ultrasound diagnosis of postpartum ovarian vein thrombosis: case report. Ultrasound Obstet Gynecol 2001; 18 (04) 384-386
  • 52 Savader SJ, Otero RR, Savader BL. Puerperal ovarian vein thrombosis: evaluation with CT, US, and MR imaging. Radiology 1988; 167 (03) 637-639
  • 53 Bannow BTS, Skeith L. Diagnosis and management of postpartum ovarian vein thrombosis. Hematology (Am Soc Hematol Educ Program) 2017; 2017 (01) 168-171
  • 54 Vandermeer FQ, Wong-You-Cheong JJ. Imaging of acute pelvic pain. Clin Obstet Gynecol 2009; 52 (01) 2-20
  • 55 Kelly J, Hunt BJ, Moody A. Images in cardiovascular medicine. Deep vein thrombosis demonstrated by magnetic resonance direct thrombus imaging. Circulation 2003; 107 (16) 2165
  • 56 Bilgin M, Sevket O, Yildiz S, Sharifov R, Kocakoc E. Imaging of postpartum ovarian vein thrombosis. Case Rep Obstet Gynecol 2012; 2012: 134603
  • 57 Chan WS, Rey E, Kent NE. et al; VTE in Pregnancy Guideline Working Group, Society of Obstetricians and Gynecologists of Canada. Venous thromboembolism and antithrombotic therapy in pregnancy. J Obstet Gynaecol Can 2014; 36 (06) 527-553
  • 58 Tait C, Baglin T, Watson H. et al; British Committee for Standards in Haematology. Guidelines on the investigation and management of venous thrombosis at unusual sites. Br J Haematol 2012; 159 (01) 28-38
  • 59 Abbattista M, Capecchi M, Martinelli I. Treatment of unusual thrombotic manifestations. Blood 2020; 135 (05) 326-334
  • 60 Kearon C, Akl EA, Ornelas J. et al. Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report. Chest 2016; 149 (02) 315-352
  • 61 Bauersachs R, Berkowitz SD, Brenner B. et al; EINSTEIN Investigators. Oral rivaroxaban for symptomatic venous thromboembolism. N Engl J Med 2010; 363 (26) 2499-2510
  • 62 Agnelli G, Buller HR, Cohen A. et al; AMPLIFY Investigators. Oral apixaban for the treatment of acute venous thromboembolism. N Engl J Med 2013; 369 (09) 799-808
  • 63 Schulman S, Kearon C, Kakkar AK. et al; RE-COVER Study Group. Dabigatran versus warfarin in the treatment of acute venous thromboembolism. N Engl J Med 2009; 361 (24) 2342-2352
  • 64 Büller HR, Décousus H, Grosso MA. et al; Hokusai-VTE Investigators. Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism. N Engl J Med 2013; 369 (15) 1406-1415
  • 65 Janczak DT, Mimier MK, McBane RD. et al. Rivaroxaban and apixaban for initial treatment of acute venous thromboembolism of atypical location. Mayo Clin Proc 2018; 93 (01) 40-47
  • 66 Covut F, Kewan T, Perez O. et al. Direct oral anticoagulants versus warfarin and enoxaparin in ovarian vein thrombosis. Am J Ther 2019; ; ( epub ahead of print ) DOI: 10.1097/MJT.0000000000001084.
  • 67 Cook RM, Rondina MT, Horton DJ. Rivaroxaban for the long-term treatment of spontaneous ovarian vein thrombosis caused by factor V Leiden homozygosity. Ann Pharmacother 2014; 48 (08) 1055-1060
  • 68 Naoum J, Mohsen A, Daher J, Eid T. Novel management of ovarian vein thrombosis: a case report. Saudi Pharm J 2018; 26 (05) 608-610
  • 69 Azhar E, Nguyen T, Waheed A. Left ovarian vein thrombosis presenting as acute postpartum pyelonephritis. Cureus 2020; 12 (02) e6854
  • 70 Bates SM, Greer IA, Middeldorp S, Veenstra DL, Prabulos AM, Vandvik PO. VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141 (2, Suppl): e691S-e736S
  • 71 Cohen H, Arachchillage DR, Middeldorp S, Beyer-Westendorf J, Abdul-Kadir R. Management of direct oral anticoagulants in women of childbearing potential: guidance from the SSC of the ISTH. J Thromb Haemost 2016; 14 (08) 1673-1676
  • 72 Acharya G, Singh K, Hansen JB, Kumar S, Maltau JM. Catheter-directed thrombolysis for the management of postpartum deep venous thrombosis. Acta Obstet Gynecol Scand 2005; 84 (02) 155-158
  • 73 Josey WE, Staggers Jr SR. Heparin therapy in septic pelvic thrombophlebitis: a study of 46 cases. Am J Obstet Gynecol 1974; 120 (02) 228-233
  • 74 Lenz CJ, Wysokinski WE, McBane RD. In reply. Obstet Gynecol 2018; 131 (04) 741-742
  • 75 Al-toma A, Heggelman BG, Kramer MH. Postpartum ovarian vein thrombosis: report of a case and review of literature. Neth J Med 2003; 61 (10) 334-336
  • 76 Kolluru A, Lattupalli R, Kanwar M, Behera D, Kamalakannan D, Beeai MK. Postpartum ovarian vein thrombosis presenting as ureteral obstruction. BMJ Case Rep 2010; 2010: bcr0320102863